Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1990;82:1424-1437

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinusas, A. J.
Right arrow Articles by Beller, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinusas, A. J.
Right arrow Articles by Beller, G. A.

Circulation, Vol 82, 1424-1437, Copyright © 1990 by American Heart Association


ARTICLES

Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile

AJ Sinusas, KA Trautman, JD Bergin, DD Watson, M Ruiz, WH Smith and GA Beller
Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville 22908.

Serial myocardial imaging with technetium-99m methoxyisobutyl isonitrile (99mTc-MIBI) has been proposed for evaluating myocardial salvage after reperfusion. To define 99mTc-MIBI uptake before and after reperfusion, 17 open-chest dogs underwent 3 hours of left anterior descending artery occlusion and 3 hours of reperfusion. 99mTc-MIBI was injected during occlusion (group 1) or after 90 minutes of reperfusion (group 2). Myocardial 99mTc-MIBI activity was correlated with microsphere flow during occlusion and reperfusion. Anatomic risk area and infarct area were defined by postmortem vital staining and correlated with the perfusion defects defined by analysis of 99mTc-MIBI macroautoradiographs and gamma camera images of myocardial slices. The left ventricle was divided into 96 segments for gamma well counting. Flow and 99mTc-MIBI activity were normalized to nonischemic values. Myocardial segments were grouped, based on occlusion flow, into zones: severely ischemic (less than or equal to 30% nonischemic), moderately ischemic (greater than 30%, less than or equal to 60% nonischemic), mildly ischemic (greater than 60%, less than or equal to 90% nonischemic), and nonischemic (greater than 90%, less than or equal to 120% nonischemic). Among dogs injected with 99mTc-MIBI during coronary occlusion (group 1), myocardial 99mTc-MIBI activity correlated linearly with occlusion flow for both endocardial (r = 0.91) and transmural (r = 0.91) segments. The risk area defined by 99mTc-MIBI autoradiography (group 1) correlated with the postmortem risk area (rho = 0.94) but was 29% smaller than the anatomic risk area (p = 0.03), reflecting the contribution of collateral flow. Among dogs injected with 99mTc-MIBI after reperfusion (group 2), myocardial 99mTc-MIBI did not correlate with reperfusion flow in either endocardial or transmural segments. Among group 2 dogs, myocardial 99mTc-MIBI activity was significantly less than reperfusion flow at the time of injection in the severely ischemic (25 +/- 5% versus 74 +/- 24% nonischemic, p = 0.002), moderately ischemic (54 +/- 12% versus 96 +/- 15% nonischemic, p = 0.001), and mildly ischemic (84 +/- 6% versus 93 +/- 3% nonischemic, p = 0.002) zones. The defect area defined by 99mTc-MIBI autoradiography (group 2) correlated very closely with the postmortem infarct area (rho = 0.98). Thus, the myocardial uptake of 99mTc-MIBI during coronary occlusion correlates with occlusion flow and reflects the "area at risk." When 99mTc-MIBI was given after 90 minutes of reperfusion following 3 hours of coronary occlusion, the myocardial activity was significantly reduced compared with reperfusion flow in both necrotic and perinecrotic regions, reflecting myocardial viability more than the degree of reperfusion.


This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
J. T. Ortiz-Perez, J. Rodriguez, S. N. Meyers, D. C. Lee, C. Davidson, and E. Wu
Correspondence Between the 17-Segment Model and Coronary Arterial Anatomy Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging
J. Am. Coll. Cardiol. Img., May 1, 2008; 1(3): 282 - 293.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
O. Pereztol-Valdes, J. Candell-Riera, C. Santana-Boado, J. Angel, S. Aguade-Bruix, J. Castell-Conesa, E. V. Garcia, and J. Soler-Soler
Correspondence between left ventricular 17 myocardial segments and coronary arteries
Eur. Heart J., December 2, 2005; 26(24): 2637 - 2643.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
A. Natanzon, A. H. Aletras, L.-Y. Hsu, and A. E. Arai
Determining Canine Myocardial Area at Risk with Manganese-enhanced MR Imaging
Radiology, September 1, 2005; 236(3): 859 - 866.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. J. Slomka, D. Fieno, L. Thomson, J. D. Friedman, S. W. Hayes, G. Germano, and D. S. Berman
Automatic Detection and Size Quantification of Infarcts by Myocardial Perfusion SPECT: Clinical Validation by Delayed-Enhancement MRI
J. Nucl. Med., May 1, 2005; 46(5): 728 - 735.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Ibrahim, S. G. Nekolla, M. Hornke, H. P. Bulow, J. Dirschinger, A. Schomig, and M. Schwaiger
Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: Comparison with single-photon emission tomography using Tc99m-sestamibi
J. Am. Coll. Cardiol., February 15, 2005; 45(4): 544 - 552.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
L. Argaud, G. Rioufol, M. Lievre, L. Bontemps, P. Legalery, M. Stumpf, G. Finet, R. Itti, X. Andre-Fouet, and M. Ovize
Preconditioning during coronary angioplasty: no influence of collateral perfusion or the size of the area at risk
Eur. Heart J., November 2, 2004; 25(22): 2019 - 2025.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Ndrepepa, J. Mehilli, M. Schwaiger, H. Schuhlen, S. Nekolla, S. Martinoff, C. Schmitt, J. Dirschinger, A. Schomig, and A. Kastrati
Prognostic Value of Myocardial Salvage Achieved by Reperfusion Therapy in Patients with Acute Myocardial Infarction
J. Nucl. Med., May 1, 2004; 45(5): 725 - 729.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. B. Fram, R. R. Azar, A. W. Ahlberg, L. D. Gillam, J. F. Mitchel, F. J. Kiernan, J. A. Hirst, J. F. Mather, E. Ficaro, G. Cyr, et al.
Duration of abnormal SPECT myocardial perfusion imaging following resolution of acute ischemia: an angioplasty model
J. Am. Coll. Cardiol., February 5, 2003; 41(3): 452 - 459.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Z. Liu, G. A. Kastis, G. D. Stevenson, H. H. Barrett, L. R. Furenlid, M. A. Kupinski, D. D. Patton, and D. W. Wilson
Quantitative Analysis of Acute Myocardial Infarct in Rat Hearts with Ischemia-Reperfusion Using a High-Resolution Stationary SPECT System
J. Nucl. Med., July 1, 2002; 43(7): 933 - 939.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. W. Dae, D. W. Gao, D. I. Sessler, K. Chair, and C. A. Stillson
Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in human-sized pigs
Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1584 - H1591.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Iwakura, H. Ito, S. Kawano, Y. Shintani, K. Yamamoto, A. Kato, M. Ikushima, K. Tanaka, M. Kitakaze, M. Hori, et al.
Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction
J. Am. Coll. Cardiol., August 1, 2001; 38(2): 472 - 477.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
U. Sechtem
Imaging myocardial area at risk and final infarct size
Eur. Heart J. Suppl., June 1, 2001; 3(suppl_C): C36 - C46.
[PDF]


Home page
NEJMHome page
A. Schomig, A. Kastrati, J. Dirschinger, J. Mehilli, U. Schricke, J. Pache, S. Martinoff, F.-J. Neumann, M. Schwaiger, and The Stent versus Thrombolysis for Occluded Coronar
Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction
N. Engl. J. Med., August 10, 2000; 343(6): 385 - 391.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. J. Gibbons, T. D. Miller, and T. F. Christian
Infarct Size Measured by Single Photon Emission Computed Tomographic Imaging With 99mTc-Sestamibi : A Measure of the Efficacy of Therapy in Acute Myocardial Infarction
Circulation, January 4, 2000; 101(1): 101 - 108.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Saeed, J. Bremerich, M. F. Wendland, R. Wyttenbach, H.-J. Weinmann, and C. B. Higgins
Reperfused Myocardial Infarction as Seen with Use of Necrosis-specific versus Standard Extracellular MR Contrast Media in Rats
Radiology, October 1, 1999; 213(1): 247 - 257.
[Abstract] [Full Text]


Home page
CirculationHome page
N. Takahashi, C. P. Reinhardt, R. Marcel, and J. A. Leppo
Myocardial Uptake of 99mTc-Tetrofosmin, Sestamibi, and 201Tl in a Model of Acute Coronary Reperfusion
Circulation, November 15, 1996; 94(10): 2605 - 2613.
[Abstract] [Full Text]


Home page
CirculationHome page
R. Medrano, R. W. Lowry, J. B. Young, D. G. Weilbaecher, L. H. Michael, I. Afridi, Z.-X. He, J. J. Mahmarian, and M. S. Verani
Assessment of Myocardial Viability With 99mTc Sestamibi in Patients Undergoing Cardiac Transplantation: A Scintigraphic/Pathological Study
Circulation, September 1, 1996; 94(5): 1010 - 1017.
[Abstract] [Full Text]


Home page
CirculationHome page
G. L. Schaer, L. J. Spaccavento, K. F. Browne, K. A. Krueger, D. Krichbaum, J. M. Phelan, W. O. Fletcher, C. L. Grines, S. Edwards, M. K. Jolly, et al.
Beneficial Effects of RheothRx Injection in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
Circulation, August 1, 1996; 94(3): 298 - 307.
[Abstract] [Full Text]


Home page
CirculationHome page
V. Sansoy, D. K. Glover, D. D. Watson, M. Ruiz, W. H. Smith, J. P. Simanis, and G. A. Beller
Comparison of Thallium-201 Resting Redistribution With Technetium-99m–Sestamibi Uptake and Functional Response to Dobutamine for Assessment of Myocardial Viability
Circulation, August 15, 1995; 92(4): 994 - 1004.
[Abstract] [Full Text]


Home page
CirculationHome page
T. D. Miller, T. F. Christian, M. R. Hopfenspirger, D. O. Hodge, B. J. Gersh, and R. J. Gibbons
Infarct Size After Acute Myocardial Infarction Measured by Quantitative Tomographic 99mTc Sestamibi Imaging Predicts Subsequent Mortality
Circulation, August 1, 1995; 92(3): 334 - 341.
[Abstract] [Full Text]


Home page
NEJMHome page
R. J. Gibbons, D. R. Holmes, G. S. Reeder, K. R. Bailey, M. R. Hopfenspirger, B. J. Gersh, and The Mayo Coronary Care Unit and Catheterization La
Immediate Angioplasty Compared with the Administration of a Thrombolytic Agent Followed by Conservative Treatment for Myocardial Infarction
N. Engl. J. Med., March 11, 1993; 328(10): 685 - 691.
[Abstract] [Full Text]


Home page
CirculationHome page
H. Matsuo, S. Watanabe, T. Kadosaki, T. Yamaki, S. Tanaka, S. Miyata, T. Segawa, Y. Matsuno, M. Tomita, and H. Fujiwara
Validation of Collateral Fractional Flow Reserve by Myocardial Perfusion Imaging
Circulation, March 5, 2002; 105(9): 1060 - 1065.
[Abstract] [Full Text] [PDF]